相关实验视频

Updated: Jan 7, 2026

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

莱什马尼亚的拉巴胺素 (TOR) 激酶的标:与Trypanosomatids进行比较分析的见解

Soumi Chowdhury¹, Harsh Pawar²

¹Manipal Academy of Higher Education, Manipal- 576104 Karnataka, India; Institute of Bioinformatics, International Technology Park Limited, Whitefield, Bangalore 560066, India.

|December 9, 2025

概括

莱什曼尼亚寄生虫有四个独特的拉巴胺素 (TOR) 基因目标,与其他真核生物不同. 这项研究揭示了Leishmania TOR类型的功能多样化,为leishmaniasis提供了潜在的药物标.

科学领域:

分子生物学分子生物学
寄生虫学的寄生虫学
进化生物学进化生物学

背景情况:

拉巴胺素 (TOR) 激酶的向位调节细胞生长和细胞代谢.
莱什曼尼亚物种独特地拥有四个TOR类型,这表明其特殊功能超出了其他真核生物中发现的典型的一个或两个.

研究的目的:

在Leishmania物种中对TOR类型进行全面的遗传学和域分析.
研究Leishmania中TOR基因的进化扩张和功能多样化.
在TOR途径中识别潜在的药物点,用于莱什曼病治疗.

主要方法:

在多个Leishmania物种中对TOR类型的基因分析.
对TOR蛋白结构的域分析,包括FAT,FRB和PI3Kc域.
与Trypanosoma brucei的TOR蛋白质进行比较分析.

主要成果:

由于TOR1和TOR2具有高度保守的法定域,这表明它们在基本的TORC1和TORC2复合体中的作用.
TOR3和TOR4表现出显著的序列分歧和改变的域结构,TOR3与氨酸感应有关,TOR4与寄生虫适应有关.
在所有Leishmania TOR类型中都保留了PI3Kc域,为药物开发提供了潜在的目标.

结论:

莱什马尼亚的扩大TOR基因家族表明了谱系特异性进化和功能专业化.
不同的TOR对应物 (TOR3和TOR4) 可能在寄生虫特定的过程中发挥作用,例如适应和分化.
在所有TOR类型中保存的PI3Kc域代表了对抗莱什曼病的有希望的治疗标.

关键词:

这种寄生虫是kinetoplastid寄生虫.莱什曼的演变莱什曼的演变在PIKK家族的PIKK家族中.类似的多样化多样化.遗传学上的分歧.这是TOR激酶对应物.

更多相关视频

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

In Vivo Infection with Leishmania amazonensis to Evaluate Parasite Virulence in Mice

Published on: February 20, 2020

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Quantification of Intracellular Growth Inside Macrophages is a Fast and Reliable Method for Assessing the Virulence of Leishmania Parasites

Published on: March 16, 2018

相关概念视频

PI3K/mTOR/AKT Signaling Pathway

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...